doi:10.1016/j.virs.2025.03.009

[1]
Yi Hu, Jingxin Zhang, 2013: Screening Strategies to Identify Host Factors Associated with the Early and Late Stages of HIV-1 Life Cycle, Virologica Sinica, 28, 242-245. doi: 10.1007/s12250-013-3359-9
[2]
Yuhang Zhang, Zhenjiang Zhang, Fan Zhang, Jiwen Zhang, Jun Jiao, Min Hou, Nianchao Qian, Dongming Zhao, Xiaofeng Zheng, Xu Tan, 2023: ASFV transcription reporter screening system identifies ailanthone as a broad antiviral compound, Virologica Sinica, 38, 459-469. doi: 10.1016/j.virs.2023.03.004
[3]
Jia Dan, Lin Nie, Xudong Jia, Cuiying Xu, Jing Cai, Yuan Lin, Jun Hu, Wenbo Zhu, Yinyin Li, Dong Chen, Ying Liu, Cheng Hu, Guangmei Yan, Jiankai Liang, Qinfen Zhang, 2021: Visualization of the Oncolytic Alphavirus M1 Life Cycle in Cancer Cells, Virologica Sinica, 36, 655-666. doi: 10.1007/s12250-020-00339-7
[4]
Yu-Jia Shi, Jia-Qi Li, Hong-Qing Zhang, Cheng-Lin Deng, Qin-Xuan Zhu, Bo Zhang, Xiao-Dan Li, 2023: A high throughput antiviral screening platform for alphaviruses based on Semliki Forest virus expressing eGFP reporter gene, Virologica Sinica, 38, 585-594. doi: 10.1016/j.virs.2023.06.007
[5]
Chun-Guang Wu, Jian-Hua Wang, Bo Zhu, Jing Chen, 2026: Development of a stable replicon system of a pangolin merbecovirus for antiviral screening, Virologica Sinica, 41, 236-239. doi: 10.1016/j.virs.2026.02.004
[6]
Jing Chen, Bing-Jie Hu, Kai Zhao, Yun Luo, Hao-Feng Lin, Zheng-Li Shi, 2021: Development of A MERS-CoV Replicon Cell Line for Antiviral Screening, Virologica Sinica, 36, 730-735. doi: 10.1007/s12250-020-00341-z
[7]
Tolganay Kulatay, Elena Sedova, Alexander Shevtsov, Gulzat Zauatbayeva, Bakytkali Ingirbay, Viktoriya Keyer, Zhanar Shakhmanova, Maral Zhumabekova, Yergali Abduraimov, Aralbek Rsaliyev, Nurgul Sikhayeva, Irina Kozlova, Mikhail Zaripov, Alexandr V. Shustov, 2025: Synthetic genomics-based generation of the tick-borne encephalitis virus Siberian subtype prototype strain and E51K-attenuated variant for vaccine development and antiviral screening, Virologica Sinica, 40, 812-821. doi: 10.1016/j.virs.2025.09.010
[8]
Jia Dan, Lin Nie, Xudong Jia, Cuiying Xu, Jing Cai, Yuan Lin, Jun Hu, Wenbo Zhu, Yinyin Li, Dong Chen, Ying Liu, Cheng Hu, Guangmei Yan, Jiankai Liang, Qinfen Zhang, 2021: Correction to: Visualization of the Oncolytic Alphavirus M1 Life Cycle in Cancer Cells, Virologica Sinica, 36, 830-831. doi: 10.1007/s12250-021-00429-0
[9]
Yingjian Li, Xue Tan, Jikai Deng, Xuemei Liu, Qianyun Liu, Zhen Zhang, Xiaoya Huang, Chao Shen, Ke Xu, Li Zhou, Yu Chen, 2024: An optimized high-throughput SARS-CoV-2 dual reporter trans-complementation system for antiviral screening in vitro and in vivo, Virologica Sinica, 39, 447-458. doi: 10.1016/j.virs.2024.03.009
[10]
Yuan Zhang, Chunjie Li, Xianliang Ke, Dan Luo, Yan Liu, Quanjiao Chen, Hanzhong Wang, Xiaohui Song, Zhenhua Zheng, 2022: Development of a biosensor assessing SARS-CoV-2 main protease proteolytic activity in living cells for antiviral drugs screening, Virologica Sinica, 37, 459-461. doi: 10.1016/j.virs.2022.04.002
[11]
Hao Huang, Xiaobing Lu, Tianlai Hong, Yihong Chen, Meisheng Yi, Kuntong Jia, 2026: Development of the reverse genetics system for viral hemorrhagic septicemia virus genotype IVa and its application in antiviral compound screening, Virologica Sinica, 41, 107-118. doi: 10.1016/j.virs.2025.12.010
[12]
Ya-Nan Zhang, Yan-Ning Hu, Yu-Jia Lu, Xiao-Dan Li, Ana Carolina Gomes Jardim, Bo Zhang, 2026: Development of a replicon cell line-based high throughput antiviral assay for screening inhibitors of Mayaro virus, Virologica Sinica, 41, 724-727. doi: 10.1016/j.virs.2026.06.012
[13]
Zhichao Yin, Yuanyuan Wu, Rui Zhu, Longfa Xu, Yu Lin, Hongwei Yang, Wenkun Fu, Qiongzi Huang, Dongqing Zhang, Jue Wang, Wei Wang, Yingbin Wang, Tong Cheng, Ningshao Xia, 2021: Development of A Neonatal Mouse Model for Coxsackievirus B1 Antiviral Evaluation, Virologica Sinica, 36, 1575-1584. doi: 10.1007/s12250-021-00444-1
[14]
Yue Lu, Ping He, Yuxuan Zhang, Yongwen Ren, Leiliang Zhang, 2022: The emerging roles of retromer and sorting nexins in the life cycle of viruses, Virologica Sinica, 37, 321-330. doi: 10.1016/j.virs.2022.04.014
[15]
Ruikun Du, Qinghua Cui, Zinuo Chen, Xiujuan Zhao, Xiaojing Lin, Lijun Rong, 2023: Revisiting influenza A virus life cycle from a perspective of genome balance, Virologica Sinica, 38, 1-8. doi: 10.1016/j.virs.2022.10.005
[16]
Ren-rong TIAN, Qing-jiao LIAO, Xu-lin CHEN, 2007: Current Status of Targets and Assays for Anti-HIV Drug Screening, Virologica Sinica, 22, 476-485.
[17]
Jing-Wei Zhang, Han Wang, Jing Liu, Le Ma, Rong-Hong Hua, Zhi-Gao Bu, 2021: Generation of A Stable GFP-reporter Zika Virus System for High-throughput Screening of Zika Virus Inhibitors, Virologica Sinica, 36, 476-489. doi: 10.1007/s12250-020-00316-0
[18]
Qiu-Yan Zhang, Jia-Qi Li, Qi Li, Yang Zhang, Zhe-Rui Zhang, Xiao-Dan Li, Hong-Qing Zhang, Cheng-Lin Deng, Feng-Xia Yang, Yi Xu, Bo Zhang, 2024: Identification of fangchinoline as a broad-spectrum enterovirus inhibitor through reporter virus based high-content screening, Virologica Sinica, 39, 301-308. doi: 10.1016/j.virs.2024.02.006
[19]
Yue Chen, Ronghua Chen, Jianrong Gao, Chunyuan Li, Jun Liu, Zhijian Zhou, Ruiwen Ren, 2021: Effects of Overwintering on the Survival and Vector Competence of Aedes albopictus in the Urban Life Cycle of Dengue Virus in Guangzhou, China, Virologica Sinica, 36, 755-761. doi: 10.1007/s12250-021-00356-0
[20]
Louise T. Chow, 2015: Model systems to study the life cycle of human papillomaviruses and HPV-associated cancers, Virologica Sinica, 30, 92-100. doi: 10.1007/s12250-015-3600-9